Evidence map›Paper›PMID 27799724›Full record

ArticleMediators of inflammation2016

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia.

Carmen Rădulescu, Anca Bacârea, Adina Huțanu, Rozalia Gabor, Minodora Dobreanu

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 49 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. What Do We Know about Peripartum Cardiomyopathy? Yesterday, Today, Tomorrow.International journal of molecular sciences · 2024
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Diagnostic biomolecules and combination therapy for pre-eclampsia.Reproductive biology and endocrinology : RB&E · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Carmen RădulescuDepartment of Obstetrics and Gynecology II, University of Medicine and Pharmacy of Tîrgu Mureș, Târgu Mureș, Romania.
Anca BacâreaDepartment of Pathophysiology, University of Medicine and Pharmacy of Tîrgu Mureș, Târgu Mureș, Romania.ORCID 0000-0002-9473-0287
Adina HuțanuCCAMF of University of Medicine and Pharmacy of Tîrgu Mureș, Târgu Mureș, Romania; Department of Laboratory Medicine, University of Medicine and Pharmacy of Tîrgu Mureș, Târgu Mureș, Romania.
Rozalia GaborDepartment of Management and Economy, University Petru Maior of Tîrgu Mureș, Târgu Mureș, Romania.
Minodora DobreanuCCAMF of University of Medicine and Pharmacy of Tîrgu Mureș, Târgu Mureș, Romania; Department of Laboratory Medicine, University of Medicine and Pharmacy of Tîrgu Mureș, Târgu Mureș, Romania.
Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · ROUniversitatea Petru Maior din Tîrgu Mureş · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Preeclampsia (PE), an important cause of maternal and perinatal morbidity and mortality worldwide, is a pregnancy-related disease characterized by hypertension and proteinuria after 20 weeks of gestation. The aim of our study was to find a practical panel of biomarkers useful in early diagnosis of PE. This study was carried out at the Obstetrics and Gynecology Department in Tîrgu Mureș University Hospital, Romania, between January 2014 and July 2015 and included 68 pregnant women (47 preeclamptic women and 21 controls) with gestational age between 16 and 20 weeks at enrollment. The biomarkers PlGF, sFlt-1, sEng, IL-6, and IL-16 were determined by ELISA test. We compared the serum levels of soluble markers analysed in preeclamptic women and controls during the second and third trimesters of pregnancy and we found that the best predictor for PE was PlGF with a sensitivity of 100% at a concentration threshold of 120.16 pg/mL, a diagnosis accuracy of 70.8%, and AUC of 0.684 (

Indexed as

AdultBiomarkersBody Mass IndexEndoglinEnzyme-Linked Immunosorbent AssayFemaleHumansInterleukin-16Interleukin-6Placenta Growth FactorPre-EclampsiaPregnancyVascular Endothelial Growth Factor Receptor-1Young AdultBiomarkersEndoglinInterleukin-16Interleukin-6Placenta Growth FactorVascular Endothelial Growth Factor Receptor-1

Identifiers

PMID27799724
PMCPMC5069373
OpenAlexW2528385298

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.